Various media reports from
last week suggested that Estee Lauder Companies Inc (NYSE: EL) may be looking to sell itself, and companies including Unilever plc (ADR)
(NYSE: UL), Procter & Gamble Co (NYSE: PG) and L'Oreal SA (ADR) (OTC: LRLCY) could be potential buyers.
One of the media reports suggested that L'Oreal offered $122.80 per share to acquire Estee Lauder, which represents a 15 percent premium to its closing price Friday, Bernstein's
Andrew Wood noted in a research report. The proposed offer, if true,
would value Estee Lauder at $45 billion, 4.0x sales, and 21.5x EBITDA — all of which are "high" compared to previous deals in the
space.
However, should a bidding war take place between major players including L'Oreal and Unilever, an eventual acquisition price of
$144 per share would "not be out of the question," Wood continued. Current financing rates remain low at around 2 percent, and an
acquisition financed purely through debt would still be "nicely accretive" to Unilever's earnings per share by 9 percent, L'Oreal's
earnings per share by 16 percent and P&G's earnings per share by 6 percent.
L'Oreal could also sell its 9.15 percent stake in Sanofi SA (ADR) (NYSE: SNY), which is worth north of $11 billion, and would lower its net debt/EBITDA
multiple to 4.6x, which would be good enough to avoid the need to raise equity to finance the deal.
Before investors jump to any conclusions it is equally important to consider if the Lauder family even wants to sell the
company, the analyst stated. The Lauder family owns more than 40 percent of all outstanding shares but controls 87 percent of the
beauty company's vote so any eventual sale will be the family's decision.
"We have not seen or heard any indication that the family has been interested in selling the company over the years," Wood
wrote.
Bottom line, Estee Lauder is also facing some challenges through lost sales in closing department stores and brand
fragmentation. Perhaps these challenges may prompt the Lauder family to change their mind "a little."
Bernstein still rates Estee Lauder at Outperform with an unchanged price target at $117.
Related Links:
Estee
Lauder Upgraded After Q4 Report Shows Higher Sales, Lower Costs
Jefferies
Sees Beauties And Beasts In The Modern Cosmetic Space
_______
Image Credit: By Pear285 at English Wikipedia - Transferred from en.wikipedia to Commons., CC0, via Wikimedia Commons
Latest Ratings for EL
Date |
Firm |
Action |
From |
To |
Aug 2017 |
Morgan Stanley |
Maintains |
|
Overweight |
Aug 2017 |
Argus |
Upgrades |
Hold |
Buy |
Aug 2017 |
Bank of America |
Maintains |
|
Buy |
View More Analyst Ratings for
EL
View the Latest Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.